Preview

Osteoporosis and Bone Diseases

Advanced search

21st European Congress of Endocrinology. A review of reports on calcium and phosphate metabolism, osteoporosis and other bone diseases

Abstract

On May 18-21, 2019, the 21st European Congress of Endocrinology was held in Lyon (France), bringing together a record number of participants - more than 4,000 specialists from Europe, the USA, Canada, Israel, Saudi Arabia, Russia and the CIS countries . The past congress is an extremely important event in the endocrinological scientific community, providing an opportunity to learn about the latest achievements in the field of endocrinology and fundamental medicine from leading world experts, researchers and clinicians. Traditionally, the European Endocrinology Congress discusses the most pressing issues, including those related to the latest developments in the field of diabetology, thyroidology, obesity, reproductive endocrinology, neuroendocrinology, medical genetics, etc. In addition, this year, the problem of the pathology of phosphorus-calcium metabolism was widely covered, from the most common diseases of primary hypeptarthrosis and osteoporosis to rare genetically determined bone diseases.

About the Author

Anna K. Eremkina
Endocrinology Research Centre
Russian Federation


References

1. Leder BZ, Tsai JN, Uihlein AV, et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. The Lancet. 2015;386(9999):1147-1155. doi: https://doi.org/10.1016/s0140-6736(15)61120-5

2. Strasser-Weippl K, Sudan G, Ramjeesingh R, et al. Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27. Eur. J. Cancer. 2018;90:19-25. doi: https://doi.org/10.1016/j.ejca.2017.11.014

3. Kim K, Kim I-J, Pak K, et al. Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy. J. Clin. Endocr. Metab. 2018;103(11):4232-4240. doi: https://doi.org/10.1210/jc.2017-02704

4. Zhang J, Li W, Liu J, et al. Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: An update by meta-analysis. Mol. Cell. Endocrinol. 2012;355(1):135-142. doi: https://doi.org/10.1016/j.mce.2012.02.003

5. Silvis K, Aronsson CA, Liu X, et al. Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study. Pediatr. Diabetes. 2018. doi: https://doi.org/10.1111/pedi.12794


Review

For citations:


Eremkina A.K. 21st European Congress of Endocrinology. A review of reports on calcium and phosphate metabolism, osteoporosis and other bone diseases. Osteoporosis and Bone Diseases. 2019;22(1):30-33. (In Russ.)

Views: 932


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)